Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VNRX
VNRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VNRX News
VolitionRx Reports 300% Q1 Revenue Growth and Key Developments
4d ago
Newsfilter
VolitionRX Reports Significant Q1 2026 Revenue Growth
May 15 2026
Yahoo Finance
VolitionRx Limited Reports Q1 2026 Earnings with Key Milestones
May 15 2026
seekingalpha
VolitionRX Q1 Earnings Beat Expectations with Significant Revenue Growth
May 15 2026
seekingalpha
VolitionRx to Host Q1 2026 Earnings Call
May 11 2026
Newsfilter
VolitionRx Achieves Major Milestone in Blood Testing Technology
Apr 29 2026
Newsfilter
VolitionRx Receives NYSE Compliance Plan Approval
Apr 23 2026
seekingalpha
VolitionRx Launches rNuQ Webshop to Expand Product Line
Apr 20 2026
Newsfilter
VolitionRX Reports 133% Revenue Growth in Q4 2025
Apr 03 2026
Yahoo Finance
VolitionRx Q4 2025 Earnings Call Highlights
Apr 01 2026
seekingalpha
VolitionRX Reports 40% Revenue Growth in FY
Apr 01 2026
seekingalpha
VolitionRx Secures €2 Million Non-Dilutive Financing
Mar 31 2026
seekingalpha
Nu.Q® Biomarkers Clinical Study Published in Shock Journal
Mar 30 2026
Newsfilter
VolitionRx to Host Earnings Call on April 1, 2026
Mar 25 2026
Newsfilter
VolitionRx's Breakthrough Liquid Biopsy Technology Achieves High Detection Rates
Mar 25 2026
NASDAQ.COM
VolitionRx Achieves Breakthrough with New Liquid Biopsy Method
Mar 25 2026
stocktwits
Show More News
